| 2024-06-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP and CMO | 2,280 0.0009% | $478.00 | $1.09M | -0.43% | |
| 2024-05-29 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP and CMO | 2,280 0.0009% | $445.56 | $1.02M | +7.68% | |
| 2023-11-14 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP and CMO | 5,650 0.0023% | $380.82 | $2.15M | +12.47% | |
| 2023-10-31 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP and CMO | 5,651 0.0022% | $355.92 | $2.01M | +14.76% | |
| 2023-10-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP and CMO | 5,651 0.0022% | $373.25 | $2.11M | +10.54% | |
| 2023-10-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP and CMO | 5,651 0.0022% | $345.28 | $1.95M | +18.93% | |
| 2023-09-19 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP and CMO | 5,651 0.0021% | $351.00 | $1.98M | +14.27% | |
| 2023-09-05 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP and CMO | 5,651 0.0022% | $352.66 | $1.99M | +17.05% |